Anna Mondino

Vita-Salute San Raffaele University — Italy

Immunology and Microbiology · Life Sciences

43h-index8.3kcitations231works3.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(84), CAR-T cell therapy research(70), T-cell and B-cell Immunology(40), Immune Cell Function and Interaction(35), Virus-based gene therapy research(31)

Publications231 total

In Remembrance of Professor Zelig Eshhar: <i>A Life Committed to CAR-T</i>
Human Gene Therapy·2025Open Access
Abstract LB029: TIGIT deletion rescues the antitumor activity of low avidity T cells by increasing TCR signal strength
Cancer Research·2025
Blockade of αvβ6 and αvβ8 integrins with a chromogranin A-derived peptide inhibits TGFβ activation in tumors and suppresses tumor growth
Journal of Experimental & Clinical Cancer Research·2025· 3 citedOpen Access
Highlighting recent achievements to advance more effective cancer immunotherapy
Journal of Experimental & Clinical Cancer Research·2025· 3 citedOpen Access
Non-canonical antigens are the largest fraction of peptides presented by MHC class I in mismatch repair deficient murine colorectal cancer
Genome Medicine·2024· 15 citedOpen Access
A preclinical mouse model of hepatic metastasis to instruct effective treatment modalities
Methods in cell biology·2024· 1 cited
IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer
Nature·2023· 302 cited
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6 <sup>th</sup> annual ImmunoRad conference
OncoImmunology·2023· 12 citedOpen Access
Leveraging the Tumor Immune Microenvironment To Overcome Genitourinary Cancers
European Urology Oncology·2023
Data from T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors
2023Open Access
Supplementary Figure S4 from T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors
2023Open Access
Supplementary Figure S5 from T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors
2023Open Access
Supplementary Methods and References. from T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors
2023Open Access
Figure S2 from The Transcriptional Regulator Sin3A Contributes to the Oncogenic Potential of STAT3
2023Open Access
Figure S2 from The Transcriptional Regulator Sin3A Contributes to the Oncogenic Potential of STAT3
2023Open Access
Figure S7 from The Transcriptional Regulator Sin3A Contributes to the Oncogenic Potential of STAT3
2023Open Access
Supplementary Table and Figure Legends from T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors
2023Open Access
Supplementary Table and Figure Legends from T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors
2023Open Access
Data from Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell Therapy
2023Open Access
Figure S1 from The Transcriptional Regulator Sin3A Contributes to the Oncogenic Potential of STAT3
2023Open Access
page 1 of 12Next →

Frequent Co-authors

Veronica Basso(12), Marc K. Jenkins(9), Chiara Bonini(6), Matteo Bellone(6), Fabio Ciceri(4), Alexander Khoruts(4), Daniel L. Mueller(4), Francesco Blasi(4), Joseph Schlessinger(4), Kathryn A. Pape(4), Matteo Grioni(4), Angelo Corti(4), Elena Provasi(3), Attilio Bondanza(3), Claudio Bordignon(3), Sara Colombetti(3), Claudio Doglioni(3), Maurilio Ponzoni(3), Flavio Curnis(3), Massimo Freschi(3)